SEC Company Response from C4 Therapeutics, (CCCC) — Jun 14, 2021
C4 Therapeutics, Inc.
Date: June 14, 2021 · CIK: 0001662579 · Accession: 0001193125-21-190139
AI Filing Summary & Sentiment
Letter
Re: C4 Therapeutics, Inc.
June 14, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jane Park
Registration Statement on Form S-1
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:01 p.m. Eastern Time, on June 16, 2021 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
J.P. MORGAN SECURITIES LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 14, 2021 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jane Park Re: C4 Therapeutics, Inc. Registration Statement on Form S-1 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:01 p.m. Eastern Time, on June 16, 2021 or as soon thereafter as practicable. [Signature page follows] Very truly yours, J.P. MORGAN SECURITIES LLC JEFFERIES LLC EVERCORE GROUP L.L.C. As representatives of the Underwriters J.P. MORGAN SECURITIES LLC By: /s/ David Ke Name: David Ke Title: Managing Director JEFFERIES LLC By: /s/ Dustin Tyner Name: Dustin Tyner Title: Managing Director EVERCORE GROUP L.L.C. By: /s/ Maren Winnick Name: Maren Winnick Title: Senior Managing Director [Signature Page to C4 Therapeutics, Inc. Acceleration Request]